Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![@adamfeuerstein Avatar](https://lunarcrush.com/gi/w:26/cr:twitter::102094857.png) @adamfeuerstein Adam Feuerstein ✡️

Adam Feuerstein ✡️ posts on X about $aclx, $qure, science, vivo the most. They currently have XXXXXXX followers and XX posts still getting attention that total XXXXXX engagements in the last XX hours.

### Engagements: XXXXXX [#](/creator/twitter::102094857/interactions)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::102094857/c:line/m:interactions.svg)

- X Week XXXXXXX +45%
- X Month XXXXXXXXX -XXXX%
- X Months XXXXXXXXX +40%
- X Year XXXXXXXXXX +42%

### Mentions: XX [#](/creator/twitter::102094857/posts_active)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::102094857/c:line/m:posts_active.svg)

- X Week XX -XX%
- X Month XXX -XXXX%
- X Months XXX +47%
- X Year XXXXX +61%

### Followers: XXXXXXX [#](/creator/twitter::102094857/followers)
![Followers Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::102094857/c:line/m:followers.svg)

- X Week XXXXXXX -XXXX%
- X Month XXXXXXX +0.02%
- X Months XXXXXXX +3.40%
- X Year XXXXXXX +5.20%

### CreatorRank: XXXXXXX [#](/creator/twitter::102094857/influencer_rank)
![CreatorRank Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::102094857/c:line/m:influencer_rank.svg)

### Social Influence

**Social category influence**
[stocks](/list/stocks)  #5407 [technology brands](/list/technology-brands)  XXXX% [finance](/list/finance)  XXXX% [cryptocurrencies](/list/cryptocurrencies)  XXXX%

**Social topic influence**
[$aclx](/topic/$aclx) #1, [$qure](/topic/$qure) 2.35%, [science](/topic/science) #2904, [vivo](/topic/vivo) #2876, [ash](/topic/ash) #1054, [$capr](/topic/$capr) #11, [future](/topic/future) 2.35%, [$slno](/topic/$slno) 1.18%, [$100m](/topic/$100m) 1.18%, [strong](/topic/strong) XXXX%

**Top accounts mentioned or mentioned by**
[@lizzylaw](/creator/undefined) [@statnews](/creator/undefined) [@desertdweller93](/creator/undefined) [@jukka235](/creator/undefined) [@jasonmmast](/creator/undefined) [@matthewherper](/creator/undefined) [@michaelmaiello](/creator/undefined) [@yhdjdhd](/creator/undefined) [@seedy19tron](/creator/undefined) [@kinatsofrim](/creator/undefined) [@mbrushstocks](/creator/undefined) [@fwcweather](/creator/undefined) [@amychomd](/creator/undefined) [@yusufhameed](/creator/undefined) [@jonathanwosen](/creator/undefined) [@pemulisking](/creator/undefined) [@sanctuarybio](/creator/undefined) [@msollender](/creator/undefined) [@sportsbios](/creator/undefined) [@bussinbiotech](/creator/undefined)

**Top assets mentioned**
[Arcellx, Inc. Common Stock (ACLX)](/topic/$aclx) [uniQure N.V. (QURE)](/topic/$qure) [Soleno Therapeutics, Inc. Common Stock (SLNO)](/topic/$slno) [Sarepta Therapeutics, Inc. (SRPT)](/topic/$srpt) [Scholar Rock Holding Corporation Common Stock (SRRK)](/topic/$srrk) [Gilead Sciences, Inc. (GILD)](/topic/$gild) [Johnson & Johnson (JNJ)](/topic/$jnj) [Frontline Ltd. (FRO)](/topic/$fro) [Vertex Protocol (VRTX)](/topic/$vrtx) [CRISPR Therapeutics AG (CRSP)](/topic/$crsp)
### Top Social Posts
Top posts by engagements in the last XX hours

"Friends - My humble request is that you sign up for the email version of my weekly newsletter. Its contents are also posted on STAT's website but the email arrives every Thursday at 6:30 am ET which means you can hate-read it over coffee"  
[X Link](https://x.com/adamfeuerstein/status/1849459489881174353)  2024-10-24T14:34Z 121.8K followers, 299.3K engagements


"$QURE has been talking to analysts and investors all day. The company declined to speak to me. Here's what mgmt is apparently saying about the FDA per Cantor's Kristen Kluska"  
[X Link](https://x.com/adamfeuerstein/status/1985424980754968896)  2025-11-03T19:12Z 121.8K followers, 59.6K engagements


"$SLNO is repurchasing $100M of its stock. Strong move"  
[X Link](https://x.com/adamfeuerstein/status/1988216394375430456)  2025-11-11T12:05Z 121.8K followers, 32.7K engagements


"$SRPT New Elevidys label"  
[X Link](https://x.com/adamfeuerstein/status/1989408177537057011)  2025-11-14T19:00Z 121.8K followers, 15.8K engagements


"FDA approves Otsuka kidney disease therapy"  
[X Link](https://x.com/adamfeuerstein/status/1993439226999025841)  2025-11-25T21:58Z 121.8K followers, 16.4K engagements


"$SRRK 8K re: Catalent Indiana manufacturing facility: "Catalent Indiana continues to work with the FDA to resolve the outstanding issues cited in the warning letter. Based on the November XX 2025 Type A Meeting and currently available information from Catalent Indiana the Company continues to anticipate resubmission of its biologics license application and U.S. launch of apitegromab in spinal muscular atrophy following approval in 2026.""  
[X Link](https://x.com/adamfeuerstein/status/1995827425737855299)  2025-12-02T12:08Z 121.8K followers, 14.5K engagements


"The US biopharma sector doesnt need the FDA right"  
[X Link](https://x.com/adamfeuerstein/status/1996368561858916860)  2025-12-03T23:58Z 121.8K followers, 18.1K engagements


"Part 2: Working with monkeys was this lab techs dream job. Now shes staffing an IT help desk. Experts worry that funding uncertainty under Trump will drive others from science too. By @JonathanWosen"  
[X Link](https://x.com/adamfeuerstein/status/1996566822901149997)  2025-12-04T13:06Z 121.8K followers, XXX engagements


"Here is a clip from the Kelonia #ASH XX abstract. FYI. $ACLX Results: Patients (N=3) ranged from age 61-72 and their time from diagnosis was 7.9-9.4 yrs. All had high-risk cytogenetics and 3-4 prior lines of therapy. Two were refractory to a PI an IMiD and anti-CD38 therapy. All were nave to BCMA-targeted therapies; none had extramedullary involvement. Time from consent to infusion was 13-18 days. All patients experienced treatment-emergent adverse events (AEs) primarily around infusion and during CAR-T expansion. Two patients developed infusion-related reaction (IRR) 30-60 min post-infusion"  
[X Link](https://x.com/adamfeuerstein/status/1993019409510580532)  2025-11-24T18:10Z 121.8K followers, 17.6K engagements


"Here is Vinay Prasad's memo/email in full laying out the FDA's new vaccine policy. ------ From: Prasad Vinayak Vinayak.Prasad@fda.hhs.gov Sent: Friday November XX 2025 4:21 PM To: CBER-SUBSCRIBERS-ALL CBER-SUBSCRIBERS-ALL@fda.hhs.gov Subject: Deaths in children due to COVID-19 vaccines and CBER's path forward Dear Team CBER I am writing to report that OBPV career staff have found that at least XX children have died after and because of receiving COVID-19 vaccination. These deaths are related to vaccination (likely/probable/possible attribution made by staff). That number is certainly an"  
[X Link](https://x.com/adamfeuerstein/status/1994884960894029846)  2025-11-29T21:43Z 121.8K followers, 199.3K engagements


"I wrote this for tomorrows Biotech Scorecard newsletter BEFORE Heg was named Pazdurs replacement. . Some biotech investor friends tell me I worry too much. The sector has performed exceptionally well this year despite the FDA tumult. M&A activity is red hot. Drug launches are robust. Even macro factors like interest rates and drug-pricing threats long a sector headwind are now reversing course. All true for now. But the FDA is being dismantled from the inside. If allowed to continue the repercussions will be dire even for my most optimistic biotech investor friends"  
[X Link](https://x.com/adamfeuerstein/status/1996383934494457882)  2025-12-04T00:59Z 121.8K followers, 25.8K engagements


"New data from Gilead Arcellx multiple myeloma CAR-T suggest benefit over rival treatment $GILD $ACLX $JNJ $LEGN #ASH25"  
[X Link](https://x.com/adamfeuerstein/status/1997697852726997116)  2025-12-07T16:00Z 121.8K followers, 13K engagements


"@Sanctuary_Bio $ACLX was going to sell off on ASH anyway so maybe it's just happening sooner"  
[X Link](https://x.com/adamfeuerstein/status/1993017978393334264)  2025-11-24T18:04Z 121.8K followers, 2515 engagements


"BREAKING: Top drug regulator Richard Pazdur set to leave FDA via @LizzyLaw_"  
[X Link](https://x.com/adamfeuerstein/status/1995887321653403660)  2025-12-02T16:06Z 121.8K followers, 121.6K engagements


"On $CAPR the primary endpoint was not changed. Those alleging otherwise are incorrect. The mean change on the PUL XXX endpoint was XXX points favoring deramiocel over placebo. From CEO Linda Marban: "Capricors external statistical vendor followed the pre-specified statistical analysis for the protocol specified primary endpoint of the HOPE-3 trial. This was detailed in a statistical analysis plan that was finalized prior to unblinding.""  
[X Link](https://x.com/adamfeuerstein/status/1996202926163861692)  2025-12-03T13:00Z 121.8K followers, 65K engagements


"Tracy Beth Heg Makary aide who investigated Covid vaccines to lead FDA drug center via @statnews"  
[X Link](https://x.com/adamfeuerstein/status/1996377307012092363)  2025-12-04T00:33Z 121.8K followers, 19K engagements


"Part 3: What West Virginia teens lost when CDC cuts ended their fight against Big Tobacco. What am I going to do from here on out one youth activist asks. By Sarah Todd"  
[X Link](https://x.com/adamfeuerstein/status/1996566824884805753)  2025-12-04T13:06Z 121.8K followers, 7731 engagements


"Poll: Will Marty Makary be FDA Commissioner on Monday"  
[X Link](https://x.com/adamfeuerstein/status/1997054480798326907)  2025-12-05T21:24Z 121.8K followers, 60.1K engagements


"@BussinBiotech I checked and was disappointed to not see a Polymarket or Kalshi prediction market for FDA matters"  
[X Link](https://x.com/adamfeuerstein/status/1997098363838140740)  2025-12-06T00:18Z 121.8K followers, 1493 engagements


"$ACLX sold off on the Kelonia Therapeutics (private) #ASH25 LBA1 in vivo BCMA CAR-T for multiple myeloma"  
[X Link](https://x.com/adamfeuerstein/status/1993014262122590549)  2025-11-24T17:50Z 121.8K followers, 30.1K engagements


"BREAKING: Capricor $CAPR says its cell therapy improved heart and muscle function in Duchenne patients The dual outcomes in a Phase X study will likely bolster the treatments regulatory future via @Jasonmmast and me"  
[X Link](https://x.com/adamfeuerstein/status/1996192995067208153)  2025-12-03T12:21Z 121.8K followers, 19.7K engagements


"$QURE FDA update: In the final meeting minutes and consistent with uniQures November X 2025 press release the FDA conveyed that data submitted from the Phase I/II studies of AMT-130 are currently unlikely to provide the primary evidence to support a BLA submission. uniQure is carefully evaluating the feedback and plans to urgently request a follow-up meeting with the FDA to take place in the first quarter of 2026"  
[X Link](https://x.com/adamfeuerstein/status/1996552896184229977)  2025-12-04T12:11Z 121.8K followers, 32.5K engagements


"CDC panel recommends delaying birth dose of hepatitis B vaccine via @statnews"  
[X Link](https://x.com/adamfeuerstein/status/1996968952723878382)  2025-12-05T15:44Z 121.8K followers, 6184 engagements


"Hello #ASH25 attendees STAT is hosting a free live event tonight and you're all invited. We'll be talking about the future of hematology and oncology with execs from J&J Bristol and Gilead Sciences. Plus food and drinks Details here:"  
[X Link](https://x.com/adamfeuerstein/status/1996996378279477429)  2025-12-05T17:33Z 121.8K followers, 8838 engagements


"@TheBiotechBear zilch. Orlando and New Orleans are on the regular ASH meeting rotation just not as frequently as San Diego"  
[X Link](https://x.com/adamfeuerstein/status/1997024097726091726)  2025-12-05T19:23Z 121.8K followers, 5139 engagements


"Hello If you can break away from college football for a moment. #ASH25 Day One recap $SNDX Revuforj frontline AML results $VRTX $CRSP Casgevy in young kids Star Therapeutics - Von Willebrand disease Stand up for Science buttons and a brief STAT event recap via @statnews"  
[X Link](https://x.com/adamfeuerstein/status/1997413013507523052)  2025-12-06T21:09Z 121.8K followers, 14.7K engagements


"Pluvicto - proven to benefit prostate cancer patients. Anktiva - no data no proof it does anything at all for proststr cancer patients. @ScottAdamsSays is taking both drugs. Pluvicto is helping him. Anktiva is not"  
[X Link](https://x.com/adamfeuerstein/status/1997812278788509999)  2025-12-07T23:35Z 121.8K followers, 23.2K engagements

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

@adamfeuerstein Avatar @adamfeuerstein Adam Feuerstein ✡️

Adam Feuerstein ✡️ posts on X about $aclx, $qure, science, vivo the most. They currently have XXXXXXX followers and XX posts still getting attention that total XXXXXX engagements in the last XX hours.

Engagements: XXXXXX #

Engagements Line Chart

  • X Week XXXXXXX +45%
  • X Month XXXXXXXXX -XXXX%
  • X Months XXXXXXXXX +40%
  • X Year XXXXXXXXXX +42%

Mentions: XX #

Mentions Line Chart

  • X Week XX -XX%
  • X Month XXX -XXXX%
  • X Months XXX +47%
  • X Year XXXXX +61%

Followers: XXXXXXX #

Followers Line Chart

  • X Week XXXXXXX -XXXX%
  • X Month XXXXXXX +0.02%
  • X Months XXXXXXX +3.40%
  • X Year XXXXXXX +5.20%

CreatorRank: XXXXXXX #

CreatorRank Line Chart

Social Influence

Social category influence stocks #5407 technology brands XXXX% finance XXXX% cryptocurrencies XXXX%

Social topic influence $aclx #1, $qure 2.35%, science #2904, vivo #2876, ash #1054, $capr #11, future 2.35%, $slno 1.18%, $100m 1.18%, strong XXXX%

Top accounts mentioned or mentioned by @lizzylaw @statnews @desertdweller93 @jukka235 @jasonmmast @matthewherper @michaelmaiello @yhdjdhd @seedy19tron @kinatsofrim @mbrushstocks @fwcweather @amychomd @yusufhameed @jonathanwosen @pemulisking @sanctuarybio @msollender @sportsbios @bussinbiotech

Top assets mentioned Arcellx, Inc. Common Stock (ACLX) uniQure N.V. (QURE) Soleno Therapeutics, Inc. Common Stock (SLNO) Sarepta Therapeutics, Inc. (SRPT) Scholar Rock Holding Corporation Common Stock (SRRK) Gilead Sciences, Inc. (GILD) Johnson & Johnson (JNJ) Frontline Ltd. (FRO) Vertex Protocol (VRTX) CRISPR Therapeutics AG (CRSP)

Top Social Posts

Top posts by engagements in the last XX hours

"Friends - My humble request is that you sign up for the email version of my weekly newsletter. Its contents are also posted on STAT's website but the email arrives every Thursday at 6:30 am ET which means you can hate-read it over coffee"
X Link 2024-10-24T14:34Z 121.8K followers, 299.3K engagements

"$QURE has been talking to analysts and investors all day. The company declined to speak to me. Here's what mgmt is apparently saying about the FDA per Cantor's Kristen Kluska"
X Link 2025-11-03T19:12Z 121.8K followers, 59.6K engagements

"$SLNO is repurchasing $100M of its stock. Strong move"
X Link 2025-11-11T12:05Z 121.8K followers, 32.7K engagements

"$SRPT New Elevidys label"
X Link 2025-11-14T19:00Z 121.8K followers, 15.8K engagements

"FDA approves Otsuka kidney disease therapy"
X Link 2025-11-25T21:58Z 121.8K followers, 16.4K engagements

"$SRRK 8K re: Catalent Indiana manufacturing facility: "Catalent Indiana continues to work with the FDA to resolve the outstanding issues cited in the warning letter. Based on the November XX 2025 Type A Meeting and currently available information from Catalent Indiana the Company continues to anticipate resubmission of its biologics license application and U.S. launch of apitegromab in spinal muscular atrophy following approval in 2026.""
X Link 2025-12-02T12:08Z 121.8K followers, 14.5K engagements

"The US biopharma sector doesnt need the FDA right"
X Link 2025-12-03T23:58Z 121.8K followers, 18.1K engagements

"Part 2: Working with monkeys was this lab techs dream job. Now shes staffing an IT help desk. Experts worry that funding uncertainty under Trump will drive others from science too. By @JonathanWosen"
X Link 2025-12-04T13:06Z 121.8K followers, XXX engagements

"Here is a clip from the Kelonia #ASH XX abstract. FYI. $ACLX Results: Patients (N=3) ranged from age 61-72 and their time from diagnosis was 7.9-9.4 yrs. All had high-risk cytogenetics and 3-4 prior lines of therapy. Two were refractory to a PI an IMiD and anti-CD38 therapy. All were nave to BCMA-targeted therapies; none had extramedullary involvement. Time from consent to infusion was 13-18 days. All patients experienced treatment-emergent adverse events (AEs) primarily around infusion and during CAR-T expansion. Two patients developed infusion-related reaction (IRR) 30-60 min post-infusion"
X Link 2025-11-24T18:10Z 121.8K followers, 17.6K engagements

"Here is Vinay Prasad's memo/email in full laying out the FDA's new vaccine policy. ------ From: Prasad Vinayak Vinayak.Prasad@fda.hhs.gov Sent: Friday November XX 2025 4:21 PM To: CBER-SUBSCRIBERS-ALL CBER-SUBSCRIBERS-ALL@fda.hhs.gov Subject: Deaths in children due to COVID-19 vaccines and CBER's path forward Dear Team CBER I am writing to report that OBPV career staff have found that at least XX children have died after and because of receiving COVID-19 vaccination. These deaths are related to vaccination (likely/probable/possible attribution made by staff). That number is certainly an"
X Link 2025-11-29T21:43Z 121.8K followers, 199.3K engagements

"I wrote this for tomorrows Biotech Scorecard newsletter BEFORE Heg was named Pazdurs replacement. . Some biotech investor friends tell me I worry too much. The sector has performed exceptionally well this year despite the FDA tumult. M&A activity is red hot. Drug launches are robust. Even macro factors like interest rates and drug-pricing threats long a sector headwind are now reversing course. All true for now. But the FDA is being dismantled from the inside. If allowed to continue the repercussions will be dire even for my most optimistic biotech investor friends"
X Link 2025-12-04T00:59Z 121.8K followers, 25.8K engagements

"New data from Gilead Arcellx multiple myeloma CAR-T suggest benefit over rival treatment $GILD $ACLX $JNJ $LEGN #ASH25"
X Link 2025-12-07T16:00Z 121.8K followers, 13K engagements

"@Sanctuary_Bio $ACLX was going to sell off on ASH anyway so maybe it's just happening sooner"
X Link 2025-11-24T18:04Z 121.8K followers, 2515 engagements

"BREAKING: Top drug regulator Richard Pazdur set to leave FDA via @LizzyLaw_"
X Link 2025-12-02T16:06Z 121.8K followers, 121.6K engagements

"On $CAPR the primary endpoint was not changed. Those alleging otherwise are incorrect. The mean change on the PUL XXX endpoint was XXX points favoring deramiocel over placebo. From CEO Linda Marban: "Capricors external statistical vendor followed the pre-specified statistical analysis for the protocol specified primary endpoint of the HOPE-3 trial. This was detailed in a statistical analysis plan that was finalized prior to unblinding.""
X Link 2025-12-03T13:00Z 121.8K followers, 65K engagements

"Tracy Beth Heg Makary aide who investigated Covid vaccines to lead FDA drug center via @statnews"
X Link 2025-12-04T00:33Z 121.8K followers, 19K engagements

"Part 3: What West Virginia teens lost when CDC cuts ended their fight against Big Tobacco. What am I going to do from here on out one youth activist asks. By Sarah Todd"
X Link 2025-12-04T13:06Z 121.8K followers, 7731 engagements

"Poll: Will Marty Makary be FDA Commissioner on Monday"
X Link 2025-12-05T21:24Z 121.8K followers, 60.1K engagements

"@BussinBiotech I checked and was disappointed to not see a Polymarket or Kalshi prediction market for FDA matters"
X Link 2025-12-06T00:18Z 121.8K followers, 1493 engagements

"$ACLX sold off on the Kelonia Therapeutics (private) #ASH25 LBA1 in vivo BCMA CAR-T for multiple myeloma"
X Link 2025-11-24T17:50Z 121.8K followers, 30.1K engagements

"BREAKING: Capricor $CAPR says its cell therapy improved heart and muscle function in Duchenne patients The dual outcomes in a Phase X study will likely bolster the treatments regulatory future via @Jasonmmast and me"
X Link 2025-12-03T12:21Z 121.8K followers, 19.7K engagements

"$QURE FDA update: In the final meeting minutes and consistent with uniQures November X 2025 press release the FDA conveyed that data submitted from the Phase I/II studies of AMT-130 are currently unlikely to provide the primary evidence to support a BLA submission. uniQure is carefully evaluating the feedback and plans to urgently request a follow-up meeting with the FDA to take place in the first quarter of 2026"
X Link 2025-12-04T12:11Z 121.8K followers, 32.5K engagements

"CDC panel recommends delaying birth dose of hepatitis B vaccine via @statnews"
X Link 2025-12-05T15:44Z 121.8K followers, 6184 engagements

"Hello #ASH25 attendees STAT is hosting a free live event tonight and you're all invited. We'll be talking about the future of hematology and oncology with execs from J&J Bristol and Gilead Sciences. Plus food and drinks Details here:"
X Link 2025-12-05T17:33Z 121.8K followers, 8838 engagements

"@TheBiotechBear zilch. Orlando and New Orleans are on the regular ASH meeting rotation just not as frequently as San Diego"
X Link 2025-12-05T19:23Z 121.8K followers, 5139 engagements

"Hello If you can break away from college football for a moment. #ASH25 Day One recap $SNDX Revuforj frontline AML results $VRTX $CRSP Casgevy in young kids Star Therapeutics - Von Willebrand disease Stand up for Science buttons and a brief STAT event recap via @statnews"
X Link 2025-12-06T21:09Z 121.8K followers, 14.7K engagements

"Pluvicto - proven to benefit prostate cancer patients. Anktiva - no data no proof it does anything at all for proststr cancer patients. @ScottAdamsSays is taking both drugs. Pluvicto is helping him. Anktiva is not"
X Link 2025-12-07T23:35Z 121.8K followers, 23.2K engagements

@adamfeuerstein
/creator/twitter::adamfeuerstein